StonvexLoading…
StonvexCore line items from CASY's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-04-30 | Annual 2024 2024-04-30 | Annual 2023 2023-04-30 | Annual 2022 2022-04-30 |
|---|---|---|---|---|
Revenue | $15.94B | $14.86B | $15.09B | $12.95B |
Operating Income | Not available | Not available | Not available | Not available |
Net Income | $546.52M | $501.97M | $446.69M | $339.79M |
EPS (Diluted) | $14.64 | $13.43 | $11.91 | $9.10 |
Total Assets | $8.21B | $6.35B | $5.94B | $5.51B |
Total Liabilities | $4.70B | $3.33B | $3.28B | $3.26B |
Cash & Equivalents | $326.66M | $206.48M | $378.87M | $158.88M |
Free Cash Flow OCF − CapEx | $584.63M | $370.95M | $405.38M | $462.27M |
Shares Outstanding | 37.34M | 37.01M | 37.26M | 37.11M |